Connect with us

Hi, what are you looking for?

Jewish Business News

Money

Qualcomm Misses Earnings Estimates, Slapped With Investigations

Steve Mollenkopf

Qualcomm missed earnings estimates for the fourth quarter by 5 cents and its revenues came below Wall Street expectations by $330 million. Management’s guidance for Q1 was below targets; the company expects earnings per share to be in the range of $1.18 and $1.30, which is shy of analyst targets of $1.43. Revenues are expected to be between $6.6 billion and $7.3 billion, while analysts wanted them to be at $7.39. The stock dropped 5%.

CEO Steve Mollenkopf sounded hopeful, according to Forbes, “We are pleased to report another year of record performance as our 3G/4G multimode and other advanced technologies continue to enable the growth of wireless data around the world, driven by our broad chipset roadmap.”

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

However, all over the world might have meant in places other than China, which was the main cause of Qualcomm’s woes this quarter. The company is still in an ongoing dispute over royalties with Chinese customers. In addition, a Chinese regulator is investigating the chipmaker. Mollenkopf said, “We also believe that certain licencees in China are not complying with their contractual obligations to report their sales of licensed products to us.”

However, China is not Qualcomm’s only problem. Management admitted that it is being investigated for regulatory problems in the U.S. and Europe, as reported by SeekingAlpha. In addition to antitrust investigations in China, it is now dealing with a probe over financial incentives of its chip sales.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...